Search research articles
Contact Us
Filters
Showing results (251-260 of 284) with videos related to
Page
of 29
Sort By:
European Journal of Dermatology : EJD
|
November 24, 2025
From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaign
Elisa Zavattaro, Chiara Airoldi, Federica Veronese, et al.
Allergy
|
June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
Andrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Clinical Drug Investigation
|
May 15, 2025
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis)
Maria Esposito, Paolo Gisondi, Chiara Assorgi, et al.
Clinical, Cosmetic and Investigational Dermatology
|
December 18, 2023
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study
Filomena Russo, Marco Galluzzo, Luca Stingeni, et al.
The Oncologist
|
February 24, 2019
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Alessio Cortellini, Sebastiano Buti, Daniele Santini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2024
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them
Claus Garbe, Ana-Maria Forsea, Teresa Amaral, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
Andrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 6, 2025
Messages for ultraviolet-radiation protection to fair-skinned populations
Lieve Brochez, Claus Garbe, Teresa Amaral, et al.
Journal for Immunotherapy of Cancer
|
March 1, 2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 284) with videos related to
Sort By:
Page
of 29
European Journal of Dermatology : EJD
|
November 24, 2025
From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaign
Elisa Zavattaro, Chiara Airoldi, Federica Veronese, et al.
Allergy
|
June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
Andrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Clinical Drug Investigation
|
May 15, 2025
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis)
Maria Esposito, Paolo Gisondi, Chiara Assorgi, et al.
Clinical, Cosmetic and Investigational Dermatology
|
December 18, 2023
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study
Filomena Russo, Marco Galluzzo, Luca Stingeni, et al.
The Oncologist
|
February 24, 2019
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
Alessio Cortellini, Sebastiano Buti, Daniele Santini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 1, 2024
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them
Claus Garbe, Ana-Maria Forsea, Teresa Amaral, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
February 7, 2022
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
Andrea Chiricozzi, Lucia Di Nardo, Marina Talamonti, et al.
Dermatology and Therapy
|
May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis)
Helena Gioacchini, Agnese Rossi, Maria Esposito, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 6, 2025
Messages for ultraviolet-radiation protection to fair-skinned populations
Lieve Brochez, Claus Garbe, Teresa Amaral, et al.
Journal for Immunotherapy of Cancer
|
March 1, 2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, et al.
Page
of 29